Peripheral Blood Endothelial Progenitors as Potential Reservoirs of Kaposi's Sarcoma-Associated Herpesvirus by Della Bella, Silvia et al.
Peripheral Blood Endothelial Progenitors as Potential
Reservoirs of Kaposi’s Sarcoma-Associated Herpesvirus
Silvia Della Bella
1*, Adriano Taddeo
1., Maria L. Calabro `
2., Lucia Brambilla
3, Monica Bellinvia
3, Elisa Bergamo
2, Mario Clerici
1,4, Maria L. Villa
1
1Laboratory of Immunology, Dipartimento di Scienze e Tecnologie Biomediche, Universita ` degli Studi di Milano, Milan, Italy, 2UOC Immunology and
Diagnostic Molecular Oncology, Istituto Oncologico Veneto, IRCCS, Padova, Italy, 3Department of Dermatology, IRCCS Ospedale Maggiore, Milan,
Italy, 4Centro Santa Maria Nascente, IRCCS Fondazione Don Gnocchi, Milan, Italy
Background. The cellular reservoirs of Kaposi’s sarcoma-associated herpesvirus (KSHV) and the exact nature of the putative
KSHV-infected circulating precursor of spindle cells of Kaposi’s sarcoma (KS) still remain poorly defined. Because KS spindle
cells are thought to be of endothelial origin, and because mature endothelial cells do not sustain persistent KSHV-infection,
our attention was focalized on circulating hematopoietic precursors able to differentiate into endothelial lineage. Methods
and Findings. Late endothelial progenitor cells (late-EPCs) were cultured from the peripheral blood mononuclear cells of 16
patients with classic KS. The presence and load of KSHV genomes were analyzed by real-time polymerase chain reaction in
DNA extracted from cells and supernatants of late-EPC cultures obtained from 7 patients. Endothelial colonies cultured from
the peripheral blood of KS patients were found to satisfy all requisites to be defined late-EPCs: they appeared from the CD14-
negative fraction of adherent cells after 11–26 days of culture, could be serially expanded in vitro, expressed high levels of
endothelial antigens but lacked leukocyte markers. Late-EPC cultures were found to harbor KSHV-DNA at variable levels and to
retain the virus after multiple passages in cells as well as in supernatants, suggesting that a quote of KSHV lytic infection may
spontaneously occur. Lytic phase induction or hypoxia could amplify virus release in supernatants. Conclusion. Our results
suggest that circulating endothelial progenitors from KS patients are KSHV-infected and support viral productive replication
and may therefore represent potential virus reservoirs and putative precursors of KS spindle cells.
Citation: Della Bella S, Taddeo A, Calabro ` ML, Brambilla L, Bellinvia M, et al (2008) Peripheral Blood Endothelial Progenitors as Potential Reservoirs of
Kaposi’s Sarcoma-Associated Herpesvirus. PLoS ONE 3(1): e1520. doi:10.1371/journal.pone.0001520
INTRODUCTION
Kaposi’s sarcoma (KS) is a multifocal angioproliferative disease of
the skin and mucosa. Central to its pathogenesis is a hyperprolifera-
tion of spindle-shaped cells, which are the prominent and hallmark
cells of KS lesions. Spindle cells are thought to be of endothelial
origin that assume the characteristic spindle shape upon infection
with KS-associated herpesvirus (KSHV), also called human
herpesvirus-8 (HHV-8), the causative agent for KS [1]. The cellular
reservoirs of KSHV infection still remain poorly defined. Previous
investigations have demonstrated KSHV infection in circulating
monocyte/macrophages and B lymphocytes of KS patients, and
suggested therefore that these cells may participate in the
dissemination of viral infection in vivo [2]. More recent studies
have demonstrated that also progenitor populations, as CD34+ cells,
can sustain persistent KSHV infection when infected in vitro, and
may therefore act as possible infection reservoir [3].
In KS patients multiple lesions, supposed to be multiclonal in
origin [4], can appear synchronously in widely dispersed areas,
without evidence of a primary tumor as a source of metastasis.
Although it cannot be excluded that KSHV may directly infect
mature endothelial cells at the site of the lesions, two main
considerations rather suggest that KS lesions may originate from
the seeding of previously infected endothelial precursors. The first
consideration derives from the observation that KS lesions often
progress during or following states of systemic inflammation, and
that KS tumors sometimes arise precisely at sites of previous local
inflammation, such as surgical wounds (a property known as the
Koebner phenomenon) [5], thus suggesting that an inflammatory
environment can elicit spindle cell proliferation from circulating
KSHV-infected precursors. The second and more stringent
consideration derives from the demonstration that recipients of
kidney allografts KSHV-negative prior to transplantation may
develop KS lesions containing KSHV-infected neoplastic cells of
donor origin. This observation clearly indicates that infected
progenitor cells from KSHV-infected donors without KS can be
seeded and undergo neoplastic transformation and progression in
the recipient immunosuppressed hosts [6]. Although it is possible
that donor-derived KS precursors might be mature endothelial cells
of the kidney, it appears far more likely that they may originate from
circulating endothelial progenitors entrapped within the graft.
A clear-cut identification of putative KSHV-infected endothelial
progenitors in the peripheral blood of KS patients is still lacking.
Therefore, in the present study we cultured circulating endothelial
progenitor cells from the blood of patients with classic KS (cKS)
and assessed their status of KSHV infection.
METHODS
Study subjects
Sixteen patients with cKS were included in the study, 10 males
and 6 females, mean age 70 years (range 47–82). All patients had
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PLoS ONE | www.plosone.org 1 January 2008 | Issue 1 | e1520histologically confirmed diagnosis of KS, were positive for anti-
HHV8 antibodies and negative for HIV. Patients in systemic
chemotherapy were excluded. Staging was performed in accor-
dance with our classification that takes into account the prevalent
type of lesions, localization, clinical behaviour, evolutive pattern
and presence of complications [7,8]. Late endothelial progenitor
cell (late-EPC) cultures were performed at a single time point on
fresh peripheral blood samples from all the patients; staging at this
time is reported in Table 1. Seven of these patients underwent
KSHV-DNA analysis and titration of KSHV-specific antibodies;
one healthy KSHV-seronegative control was included for these
analyses. Ethics approval was obtained from the local Institutional
Review Committee and a signed informed consent was obtained
from all participants.
Cultures of late-endothelial progenitor cells
Late-EPCs were generated from peripheral blood mononuclear
cells (PBMCs) of cKS patients according to methods described by
Ingram [9], with minor modifications. Briefly, PBMCs were
obtained by Ficoll density gradient centrifugation (Cedarlane,
Hornby, Canada) [10] from 30 ml of fresh venous peripheral
blood, resuspended in EGM-2 medium (Cambrex Bio Science,
Walkersville, MD) and seeded onto six-well tissue culture plates
(5610
6 cells/well) precoated with human fibronectin (1 mg/cm
2,
Sigma-Aldrich, St. Louis, MO). Four to eight wells (mean
6.076s.e. 0.37) were plated for each patient. In two experiments,
PBMCs underwent separation of CD14+ and CD14- fractions
using immunomagnetic selection with mini-magnetic-activated cell
sorter (MACS) cell isolation kit (Miltenyi Biotec, Bergisch
Gladbach, Germany) according to the manufacturer’s instructions.
After 3 days of culture, nonadherent cells and debris were
aspirated, adherent cells were washed with EGM-2 medium, and
EGM-2 medium was added to each well. Medium was changed on
day 7 and every 3 days until the first passage. Late-EPC colonies
were identified by visual inspection using an inverted microscope.
Late-EPCs were released from the original tissue culture plates by
trypsinization (trypsin 0.25%) (Euroclone, Wetherby, UK),
resuspended in EGM-2 medium, and plated onto 25 cm
2 tissue
culture flasks precoated with fibronectin for further passages.
Multiple colonies from the same patient were pooled at this step.
In one single experiment, late-EPCs obtained from a KS patient
underwent cell sorting of CD146+ cells (EPICS ALTRA Cell
Sorter; Beckman-Coulter, Fullerton, CA). Purity of CD146+ cells
before and after sorting was 98.7% and 100%, respectively. This
highly pure population of CD146+ late-EPCs was replated and
maintained in culture for further two weeks for virus analyses.
Characterization of late-endothelial progenitor cells
Cells were cultured onto fibronectin-coated, 2-chamber Lab-Tek
slides (Nalge NUNC International, Rochester, NY) and attached
cells were incubated with 10 mg/ml Dil-acetylated-low-density
lipoprotein (Dil-ac-LDL) (Molecular Probes, Eugene, OR) in
EGM-2 medium for 1 hour at 37uC. Cells were then fixed with
2% formaldehyde for 10 minutes and incubated for 1 hour with
fluorescein-isothiocyanate (FITC)-labeled Ulex Europaeus Aggluti-
nin-1 (UEA-1; Sigma-Aldrich). Alternatively, cells were fixed with
methanol, permeabilized with 0.1% Triton X-100, blocked with
10% normal goat serum (Dako, Hamburg, Germany) and incubated
with purified antibodies against human von Willebrand Factor
(vWF), endothelial nitric oxide synthase (e-NOS) or caveolin-1 (Cav-
1) (Becton-Dickinson, San Jose, CA), followed by appropriate FITC-
or phycoerythrin (PE)-conjugated secondary antibodies (Jackson
Immunoresearch, West Grove, PA). Slides were mounted in anti-
fading mounting media containing DAPI (Vectashield; Vector
Laboratories, Burlingame, CA) and examined by conventional
fluorescence-microscopy (Leitz Dialux 22 microscope system).
For antigen detection by flow cytometry, 5610
5 late-EPCs were
incubated with different anti-human monoclonal antibodies (mAbs)
for 30 minutes at 4uC in the dark. The following FITC-, PE-,
allophycocyanin (APC)- or biotin-conjugated mAbs were used: anti-
CD31, -CD45, (Becton-Dickinson); -kinase insert domain receptor
(KDR) (Sigma-Aldrich), -CD105 (Euroclone), -CD14 (Caltag
Laboratories, Burlingame, CA), -CD146 (Chemicon, Temecula,
CA), -CD34 (Miltenyi Biotec). The FASER technique was
performed for CD34 detection according to manufacturer’s
instructions (Faser kit-APC, Miltenyi Biotec). Isotype-matched
irrelevant mAbs were used as negative controls. Data were acquired
on a FACSCanto flow cytometer (Becton-Dickinson) and analyzed
using FACSDiva software. Cells were electronically gated according
to light scatter properties to exclude cell debris.
Matrigel assays were performed as described [9]. Late-EPCs were
seeded onto 96-well tissue culture plates coated with 70 mlM a t r i g e l
(Becton-Dickinson) at a cell density of 2610
4 cells per well, and
incubated at 37uC. Cells were observed during the following 12–
72 hours with inverted microscopy for capillary-like formation.
Assessment of KSHV infection
Plasma samples were analyzed for the presence and titers of
antibodies to a latency-associated nuclear antigen (LANA) and to a
lytic phase-associated structural protein encoded by ORF65, as
previously described [11]. Antibody titers were calculated as the
reciprocal of the highest plasma dilution giving positive results.
Table 1. Clinical characteristics of patients with cKS at the
time of late-EPC culture.
......................................................................
Characteristics Overall patients
No. of patients 16
Age, yr
a 70.062.4
Sex, no.
Male 10
Female 6
KS stage
b, no.
I: maculo-nodular
A4
B5
II: infiltrative
A2
B1
III: florid
A1
B2
IV: disseminated
A0
B1
aMean6standard error.
bcKS patients were classified according to our classification that takes into
account the prevalent type of lesions, localization, clinical behaviour, evolutive
pattern and presence of complications [7,8].
A=slow evolution; B=rapid evolution; rapid denotes an increase in the total
number of nodules/plaques or in the total area of plaques in the three months
following the last examination.
doi:10.1371/journal.pone.0001520.t001
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KSHV-Infected Late-EPCs in KS
PLoS ONE | www.plosone.org 2 January 2008 | Issue 1 | e1520PBMC and late-EPC cultures from 7 cKS patients and from a
healthy control were tested for the presence and load of KSHV
DNA sequences. DNA was extracted from at least 2610
5 cells and
from 200 ul of DNAse-treated culture supernatants as previously
described [12]. KSHV viral load was measured by quantitative
real-time polymerase chain reaction (PCR), as reported elsewhere
[12]. To induce KSHV lytic replication, late-EPCs were incubated
for 48 hours either with 3 mM n-butyrate (Sigma-Aldrich), or with
20 ng/ml of phorbol 12-myristate 13-acetate (TPA, Sigma-
Aldrich) [12]. Alternatively, late-EPCs were exposed to hypoxia
by incubation for 96 hours in anaerobic conditions with less than
2% oxygen (GasPack-Pouch Systems, Becton-Dickinson) [13].
Statistical analysis
The Wilcoxon signed-rank test was used to analyze the statistical
significance of data obtained in the in vitro induction of KSHV lytic
replication. Analysis was performed with OPENSTAT3 software.
RESULTS
Late-endothelial progenitor cell cultures from classic
Kaposi’s sarcoma patients
Late-EPCs were obtained from the PBMC of 16 cKS patients
whose characteristics are reported in Table 1. Small colonies
originated from adherent cells and were apparent after 11–26 days
of culture; the mean number of colonies generated from 10
6
PBMCs was 0.09060.020, equivalent to 2.8160.39 colonies from
each patient. Late-EPCs proliferated slowly during the first weeks,
but then proliferated more rapidly and could be serially expanded
in vitro through multiple passages, up to 7–10 weeks, when they
finally stopped growing and entered senescence. During these
passages the cells retained their endothelial morphology, forming
cobblestone-like monolayers (Fig. 1). Late-EPCs stained with
UEA-1, efficiently took up ac-LDL and expressed high levels of the
endothelial antigens e-NOS, vWF, Cav-1, CD31, CD105, CD146,
KDR and CD54, but were negative for the leukocyte markers
CD45 and CD14 (Fig. 2A). According to previous observations
[14], the expression of CD34 on late-EPC surface was at low
intensity and could therefore be better detected when the highly
sensitive FASER technique, instead of conventional cytometry,
was used (Fig. 2B). Finally, within 12 hours of incubation on
Matrigel, late-EPCs formed characteristic tube-like structures
assembled in a branching reticular network, indistinguishable
from those generated by a control endothelial cell line (Fig. 3). On
the whole, these data indicate that the cultures obtained from
patients with cKS satisfied all requisites to be defined late-EPCs.
Because it has been demonstrated that late-EPCs develop
exclusively from the CD14- fraction of PBMCs [15], the CD14+
and CD14- fractions were separated from PBMCs of two cKS
patients on day 0 (.98% purity by flow cytometry) and were
cultured independently. As expected, late-EPC colonies quite
similar to those obtained from unfractionated PBMCs developed
in CD14- but not in CD14+ cultures (not shown).
Analysis of KSHV presence and viral load
quantification
KSHV DNA presence and load was determined by real-time PCR
in PBMCs and late-EPC cultures from 7 cKS patients, and in one
KSHV-seronegative healthy control, as shown in Table 2. PBMC
samples from all cKS patients were found to harbor KSHV DNA
sequences [7–359 KSHV genome equivalents (GE)/10
5 cells].
Real-time PCR analyses performed on late-EPC cultures revealed
the presence of detectable amounts of KSHV genomes in all
cultures obtained from the cKS patients, whereas late-EPCs from
the healthy control were found to be negative. Moreover, KSHV
DNA was detected at variable levels in DNA extracted from
culture supernatants, suggesting that a quote of KSHV lytic
infection may spontaneously occur in these cells. To further
confirm these data and possibly analyze the trend of KSHV
infection in these cells, late-EPCs obtained from two patients were
analyzed in multiple passages. As shown in Table 2, late-EPCs
from patient KS 4 showed a peak replication level (1332 GE/ml)
in culture supernatant at day 34, followed by high levels of viral
genomes in cellular DNA obtained in the following passage,
suggesting the propagation of viral progeny to uninfected cells.
Moreover, in another patient (KS 6) KSHV DNA could be
detected in relatively high amounts even in cells and supernatants
collected from late-EPC cultures after longer periods of time (day
71), indicating that late-EPCs may retain KSHV infection until
senescence. Because none of the endothelial markers used to
characterize our cultures was singularly expressed on the totality of
late-EPCs (each single marker being expressed by up to 98.961%
of cells, Fig. 2A), we wondered whether cells expressing endothelial
markers could be responsible for KSHV infection in our cultures.
Therefore, in one experiment late-EPCs (from patient KS 7) were
sorted for the endothelial marker CD146 [15,16], replated and
analysed for viral load and release before and after cell sorting,
strictly maintaining the same culture conditions. Culture of sorted
Figure 1. Late-EPCs can be cultured from peripheral blood mononuclear cells of patients with cKS. A representative phase-contrast photograph of
a late-EPC colony, identified as a well-circumscribed monolayer of cobblestone-appearing cells, is shown. Similar colonies were obtained from 15
different patients. A) 6100 magnification, B) 6200 magnification. Late-EPCs were photographed using a Leitz Diavert microscope system.
doi:10.1371/journal.pone.0001520.g001
KSHV-Infected Late-EPCs in KS
PLoS ONE | www.plosone.org 3 January 2008 | Issue 1 | e1520CD146+ late-EPCs gave rise to cobblestone-like monolayers of
cells morphologically identical to cultures of unsorted cells. The
persistence of CD146 positivity of sorted CD146+ late-EPCs was
confirmed after 2 weeks of culture, before performing viral analysis
(Fig. 4). As shown in Table 2, the levels of viral genomes in cellular
DNA remained similar before and after sorting in basal conditions
(250 and 271 KSHV GE/10
5 cells, respectively). Also the amounts
of viral genomes spontaneously released by late-EPCs in the
supernatants were similar before and after sorting (584 and
667 KSHV GE/ml, respectively), thus suggesting that the
negligible proportion of CD146-negative cells did not represent
the source of virus in our cultures.
Figure 2. Immunophenotypic characterization of late-EPCs obtained from 15 patients with cKS. Late-EPCs express high levels of endothelial
antigens but lack leukocyte markers. A) Percentage of positive cells for the indicated antigens, data expressed as mean6standard error. B)
Representative flow cytometry analysis. Note that binding of UEA-1, uptake of ac-LDL and staining of e-NOS, vWF and Cav-1 were examined by
conventional fluorescence-microscopy. UEA-1=Ulex Europaeus Agglutinin-1; ac-LDL=acetylated-low-density lipoprotein; e-NOS=endothelial nitric
oxide synthase; vWF=von Willebrand Factor; Cav-1=caveolin-1.
doi:10.1371/journal.pone.0001520.g002
KSHV-Infected Late-EPCs in KS
PLoS ONE | www.plosone.org 4 January 2008 | Issue 1 | e1520Induction of KSHV lytic cycle
To induce the viral lytic cycle in KSHV-infected late-EPCs,
cultures from two patients were treated in parallel with n-butyrate
or TPA, whereas cultures from three other patients had sufficient
cells to be treated only with n-butyrate. KSHV genomes were
measured by real-time PCR in culture supernatants 48 hours after
induction. As reported in Fig. 5A, induction of KSHV lytic
program by chemical treatment lead to a statistically significant
increase in virus release in culture supernatants (Wilcoxon signed-
rank test, P=0.009), suggesting that late-EPCs may support
KSHV productive replication. As shown in Fig. 5B, n-butyrate
treatment of sorted CD146+ late-EPCs (from patient KS 7)
increased the release of KSHV genomes in the supernatants to the
same extent as unsorted cells (1050 and 812 KSHV GE/ml,
respectively), thus suggesting that late-EPCs with proven endo-
thelial phenotype can support viral lytic induction.
The effects of late-EPC exposure to prolonged hypoxia, which
may act in vivo as a cofactor in the development of KS lesions,
were evaluated in 2 patients. In both cultures, hypoxia induced an
increase in KSHV levels in culture supernatants. In facts, late-
EPCs from patient KS 5 showed a 5-fold increase in virus release
(from 906 to 4454 GE/ml), whereas a moderate increment was
Figure 3. Late-EPCs obtained from patients with cKS form capillary-like structures in vitro. Late-EPCs cultured in Matrigel gave rise within 12 hours
of incubation to vascular structures that were quite similar to those formed by control endothelial cell lines. A) A representative phase-contrast
photograph of the capillary-like structures formed by late-EPCs from a patient with cKS (640 magnification) is shown. B) For comparison, a
photograph of the structures formed by ECV 304 cell line (640 magnification) is shown. Capillary-like structures were photographed using a Leitz
Diavert microscope system.
doi:10.1371/journal.pone.0001520.g003
Table 2. KSHV-DNA in peripheral blood mononuclear cells and in late-EPC cultures from patients with cKS according to their
clinical stage and KSHV serology.
..................................................................................................................................................
PBMCs late-EPCs late-EPC supernatants
KSHV serology
a KSHV-DNA KSHV-DNA KSHV-DNA
Patient Gender Age KS stage
b Anti-ORF65 Anti-LANA GE/10
5 cells GE/10
5 cells GE/ml Day of culture
KS 1 F 76 1A 400 1600 17 18 335 23
KS 2 F 72 1B 100 100 51 145 468 30
KS 3 F 62 1A 800 12800 106 74 760 31
KS 4 M 80 3B – 25600 81 104 1332 34
1327 959 42
c
64 594 48
c
KS 5 M 72 1B – 6400 7 109 564 43
KS 6 M 62 2B 6400 400 359 182 906 47
335 1329 71
c
KS 7 M 77 1B – 3200 187 250 584 21
271
d 667
d 35
Healthy
control
F6 8 – – 0 0 0 3 8
aAntibody titers were calculated as the reciprocal of the highest plasma dilution giving positive results.
bcKS patients were classified according to our classification that takes into account the prevalent type of lesions, localization, clinical behaviour, evolutive pattern and
presence of complications [7,8].
cIn two patients the presence of KSHV-DNA was determined in multiple passages of unstimulated late-EPC cultures.
dKSHV-DNA determined in highly pure CD146+ late-EPCs, maintained in culture for further 2 weeks after CD146 sorting.
KSHV=Kaposi’s sarcoma-associated herpesvirus; PBMCs=peripheral blood mononuclear cells; late-EPC=late-endothelial progenitor cell;
cKS=classic Kaposi’s sarcoma; LANA=latency-associated nuclear antigen; GE=genome equivalents.
doi:10.1371/journal.pone.0001520.t002
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KSHV-Infected Late-EPCs in KS
PLoS ONE | www.plosone.org 5 January 2008 | Issue 1 | e1520Figure 4. Flow cytometry analysis showing CD146 expression on different late-EPC populations. To confirm that late-EPCs with proven
endothelial phenotype could support KSHV infection, late-EPCs from one cKS patient underwent cell sorting of CD146+ cells and were cultured for
further 2 weeks. Analysis of unsorted late-EPCs stained with isotype control (A) or anti-human CD146 mAb (B); analysis of highly purified CD146+ late-
EPCs stained with anti-human CD146 mAb immediately after sorting (C) or after 2 weeks of culture (D).
doi:10.1371/journal.pone.0001520.g004
Figure 5. Late-EPCs obtained from patients with cKS support KSHV productive replication. A) To induce KSHV lytic replication, late-EPCs from cKS
patients underwent treatment with n-butyrate (5 patients, solid lines) or TPA (2 patients, hatched lines) for 48 hours. Multiple colonies from each
patient were pooled before treatment. B) To confirm that late-EPCs with proven endothelial phenotype could support KSHV lytic replication, late-
EPCs from one cKS patient underwent cell sorting of CD146+ cells. Unsorted late-EPCs (solid line) or highly purified CD146+ late-EPCs from the same
cKS patient were cultured for further 2 weeks after sorting (hatched line) and underwent treatment with n-butyrate for 48 hours. In any case, KSHV
genomes were analyzed by real-time PCR in DNA extracted from late-EPC supernatants. P value was determined using the Wilcoxon signed-rank
test.KSHV genomes were analyzed by real-time PCR in DNA extracted from culture supernatants. KSHV=Kaposi’s sarcoma-associated herpesvirus;
TPA=phorbol 12-myristate 13-acetate.
doi:10.1371/journal.pone.0001520.g005
KSHV-Infected Late-EPCs in KS
PLoS ONE | www.plosone.org 6 January 2008 | Issue 1 | e1520observed in the culture of patient KS 6 (from 564 to 690 GE/ml).
Late-EPCs obtained from the healthy negative control were found
to be repeatedly negative for KSHV DNA sequences also in
hypoxic culture conditions (not shown).
DISCUSSION
In this report, we provide evidence that late-EPCs from the
peripheral blood of patients with cKS harbor KSHV, may support
lytic replication and may act, therefore, as viral reservoirs. The
novelty of this finding resides in the nature of late-EPCs. Among
other cell populations with endothelial features circulating in adult
peripheral blood, late-EPCs, also called outgrowth endothelial
cells (OECs) [14] or endothelial colony-forming cells (ECFCs) [9],
are the cells that contribute more directly to neovascularization
[17]. Late-EPCs derive from the CD14- fraction of circulating
mononuclear cells, may be enriched in cells that express some
combination of CD34 and KDR, uniformly express endothelial
but not leukocyte markers and are able to form capillary tubes in
vitro [18–20]. They form colonies of endothelial cells endowed
with a late and robust proliferative potential, so that they can be
passaged over 2 months ex vivo. Because they act in many aspects
like classical primitive hematopoietic progenitor cells, late-EPCs
might represent a major source of endothelial progenitors in vivo
[19,21,22], and may therefore be an optimal model for the study
of KS. Accordingly, it has been recently demonstrated that murine
bone marrow-derived endothelial progenitors, analogous to
human late-EPCs, transfected in vitro with a KSHV artificial
chromosome induce KS-like tumors in mice [23].
First of all, in this study we demonstrate that late-EPCs can be
cultured from the peripheral blood of patients with cKS.
Moreover, our results clearly indicate that late-EPCs from cKS
are infected by KSHV and may retain the virus in long-term
cultures, as late-EPCs from the totality of cKS patients studied
resulted to harbor variable amounts of viral genomes in cultures
tested up to over 2 months.
Infected spindle cells explanted from KS biopsies are known to
rapidly segregate and loose KSHV genomes when placed in
culture [24–26]. It is possible that the ability of late-EPCs to retain
longer KSHV episomes may be related to the differentiative stage
of these cells, that are not mature endothelial cells, but progenitors
endowed with high replicative potential. Another population of
circulating endothelial-featured cells able to support viral replica-
tion had been reported by Monini and colleagues [2]. They
derived spindle-like endothelial macrophages from PBMCs of KS
patients able to support KSHV infection up to 4 weeks. Although
these cells differed from late-EPCs as they expressed CD45 and
CD14 and were considered of monocytic origin, this pioneeristic
study greatly contributed to the idea that circulating endothelial
precursors may act as reservoir for KSHV infection.
The detection of viral progeny released in all the supernatants of
unstimulated cultures indicates that late-EPCs may support the
lytic replication program of KSHV and this finding may
alternatively suggest that the virus is propagated in culture by
cycles of de novo infection of late-EPCs. Accordingly, when
KSHV DNA was analyzed in subsequent passages of unstimulated
late-EPCs from patient KS 4, we could observe that the levels of
viral genomes may change over time. Whether these fluctuations
may reflect cycles of productive viral replication that may be
responsible for the continuous infection of endothelial progenitors
may deserve further investigation.
Moreover, our results indicate that the basal level of lytic
replication can be further increased not only by chemical
treatment but also by hypoxic conditions. This finding is worthy
relevant to the role that lytic KSHV replication is supposed to play
in the promotion of KS tumorigenesis by sustaining the population
of latently infected cells [23,27]. And it is still more relevant
because hypoxia-induced KSHV reactivation, demonstrated in
vitro in PEL cell lines [28], has been suggested to contribute to the
tendency of KS to occur on the lower legs due to poor circulation,
particularly in cKS patients [29]. In this respect, hypoxia may be
considered as a KS cofactor, and the ability of late-EPCs to
support viral lytic reactivation in hypoxic conditions may have
particular relevance in vivo.
In addition, the fact that late-EPCs harbor moderate amounts of
viral genomes in unstimulated conditions may be partly related to
the type of KS patients selected for the study. In fact, to avoid the
interference of confounding factors related to iatrogenic or AIDS-
related KS, we studied patients affected by the classic, Mediter-
ranean variant of the disease that is typically characterized by a
poorly aggressive course and a relatively low viral load [16,30], as
confirmed in the PBMCs of our patients. The detection of
moderate amounts of viral genomes in our cultures also suggests
that only a small proportion of late-EPCs may be infected with
KSHV. Alternatively, it may be hypothesized that the source of
virus in our cultures may be represented by the negligible
percentage of cells lacking endothelial markers. The demonstra-
tion that KSHV genomes could similarly be detected in unsorted
or CD146+ highly purified late-EPCs does not definitely exclude
this possibility but renders it unlikely.
Endothelial progenitors are thought to be contained, together
with hematopoietic stem/progenitor populations, within the pool
of circulating CD34+ cells [31]. It has been reported that
circulating CD34+ cells, that we recently demonstrated to be
increased in patients with cKS [8,32], may harbor KSHV [33].
Similarly, it has been demonstrated that circulating CD146+ cells,
which contain endothelial progenitors but also mature endothelial
cells [34], may harbor the virus, too, in KS patients [16].
However, cell subpopulations of CD34+ or CD146+ preparations
were not further characterized and therefore both the observations
are compatible with, but not demonstrative for, KSHV infection
of endothelial progenitors.
In conclusion, in this study we suggest that circulating
endothelial progenitor cells cultured from the peripheral blood
of cKS patients as late-EPCs are infected by KSHV and can
support viral lytic replication. This finding may be of crucial
importance for the comprehension of KS pathogenesis, because
late-EPCs may likely represent the KSHV-infected circulating
precursors of KS spindle cells that, as recently suggested by Gill,
may home to the permissive site and propagate to produce KS
lesions [35]. A definitive demonstration of this hypothesis will need
experimental models of in vivo tumorigenesis.
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